C.H. Robinson Q3 beat estimates, but shares fell as expense guidance rose

On Oct. 28, CHRW reported Q3 adjusted EPS of $1.80 vs. $1.75 consensus and revenue of $5.36B vs. $4.92B; shares fell 9.59% premarket to $129.82 from $143.59. Full-year SG&A guidance rose to $585M–$590M from $540M–$580M; operating cash flow was $124.1M. RXO integration and insurance costs were cited as concerns.